Tom Polen, CEO of medical technology company BD, predicts that artificial intelligence and robotics will fundamentally reshape healthcare within the next decade, rendering current systems obsolete.
Polen made the remarks during an appearance at the Consello Spark Summit, speaking with Bloomberg's Caroline Hyde. The BD executive outlined how emerging technologies will overhaul healthcare delivery and operations.
BD, a major player in medical devices and diagnostics, is positioned to capitalize on the shift toward AI-enabled systems and robotic automation in clinical settings. The company has been investing in technologies that address labor shortages, improve diagnostic accuracy, and streamline hospital operations.
Polen's assessment aligns with broader industry trends. Healthcare systems worldwide face mounting pressure from aging populations, clinician shortages, and rising costs. AI applications in diagnostics, treatment planning, and administrative tasks are already gaining traction. Robotics is expanding into surgical procedures, laboratory automation, and patient care support.
The timeline Polen suggests—a decade for transformative change—reflects the pace of technology adoption in healthcare, where regulatory approval and integration into existing infrastructure require extended implementation periods.
Malaysian Prime Minister Anwar Ibrahim will deploy an artificial intelligence version of himself with his voice to engage with the public. He becomes one of the few world leaders to adopt such technology.
Tata Consultancy Services CEO K. Krithivasan expects artificial intelligence to account for approximately 20% of the company's revenue within four to six quarters. The shift will reshape existing roles while creating new AI-focused positions across the business.
China has omitted a numeric urban job creation goal from its five-year plan for the first time in at least three decades, signaling growing concerns about employment stability as artificial intelligence accelerates across the economy.
Tencent Holdings is negotiating to become the largest shareholder in Manus, a Chinese agentic AI startup whose acquisition by Meta was blocked by Beijing regulators.